Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Physicians and patients press Montana panel to curb step‑therapy rules for metastatic cancer; insurers urge clinical guidelines
Summary
Sen. Ellie Boldman framed SB 422 as a ban on insurance 'fail‑first' step therapy for stage‑4 cancer patients; physician groups and patient advocates supported immediate access to prescribed drugs, while insurers proposed tying any limit to NCCN or peer‑reviewed oncology guidance and offered amendments to preserve evidence‑based exceptions.
Senator Ellie Boldman told the Senate Business and Labor Committee SB 422 would prohibit insurance step‑therapy (fail‑first) mandates for patients with metastatic cancer so that clinicians can obtain the medicines they judge immediately necessary for stage‑4 care.
The Montana Medical Association and oncologists testified the individualized nature of metastatic care makes…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
